You are here

arimoclomal

FDA rejection of rare disease drug leads Orphazyme to cut two thirds of staff

MedCity News

Tue, 06/29/21 - 10:55 am

Niemann-Pick disease

Orphazyme shares sink as late-stage test of 'heat shock protein' flops

Fierce Biotech

Mon, 03/29/21 - 10:33 am

heat shock protein

inclusion body myositis

clinical trials

Nearly two years after their narrow PhIII failure, Orphazyme gets speedy look at the FDA

Endpoints

Wed, 09/16/20 - 10:38 am

clinical trials

Niemann-Pick disease

CytRx to repsond to FDA letter in 4Q

Bizjournals.com

Wed, 09/9/09 - 08:36 am

CytRx rises on preclinical data for stroke drug

Yahoo/AP

Tue, 08/25/09 - 07:50 am

stroke recovery